Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Inpharmatis appoints new RA Director in Russia & CIS
Inpharmatis officially announces the appointment of Olga Zvonareva to the position of Regional Regulatory Affairs Director in Russia and the CIS countries.
As part of the international Inpharmatis team, Olga Zvonareva is to strengthen the company's position in the market of Russia and the CIS countries in the field of providing a full range of services for the registration of medicines and medical devices. Olga Zvonareva will work in the Moscow office of Inpharmatis.
Prior to joining Inpharmatis, Olga Zvonareva held the position of Director for Regulatory Affairs, Pharmacovigilance and Quality Management at the European pharmaceutical company Fresenius Kabi for over 15 years.
Inpharmatis is an international consulting group of companies headquartered in Riga, Latvia. Inpharmatis provides a full range of services for Regulatory Affairs, pharmacovigilance (PV), GMP and GDP audits, PIL Readability User Testing, as well as electronic solutions for the pharmaceutical companies and regulatory authorities in the European Union, EAEU, CIS.
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022